(Q34529205)
Statements
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections (English)
P Prokocimer
P Bien
J Surber
P Mehra
C DeAnda
29 November 2010
1 reference
1 reference
1 reference
1 reference